Skip to main content Skip to main navigation menu Skip to site footer

Correlation between Polymorphisms Interleukin-1 Receptor Antagonist (IL-1RA) And Melasma Severity: A Study of Javanese Female Population in Yogyakarta

Abstract

Background: IL-1 is postulated as a cytokine that plays a fundamental role in the pathophysiology of several skin disorders or diseases. Melasma is a form of hyperpigmentation with a symmetrically distributed predilection for facial features. Due to its elusive pathogenesis, it is believed that the inflammatory factor plays a role in melasma. Increased or decreased IL-1RA concentrations may correlate with the severity of melasma. Therefore, this study aimed to examine the correlation between the IL-1RA (86bp VNTR) polymorphisms and the severity of melasma among a Javanese female population.

Methods: The study involved 79 individuals with melasma and used a cross-sectional design. The severity of melasma was assessed using the MASI (Melasma Area and Severity Index). The data were analyzed using a Chi-square test and Odds Ratio (OR). The genomic DNA from the patients' blood was examined and analyzed using the polymerase chain reaction (PCR) method.

Results: There was an increase in the frequency of IL-1Ra*1/1(410/410) genotype in melasma with a mild severity and of IL-1Ra*1/2(410/240) genotype in melasma with moderate severity (OR: 0.74, 95%CI: 0.26- 2.13, p: 0.42). The allele frequency of IL-1Ra*1/1 was 55.70% at a mild degree and 44.30% at a moderate degree (OR: 0.29-2.11, p: 0.65). 

Conclusions: There was no correlation between IL-1Ra VNTR and the severity of melasma; however, it was found that the IL-1Ra*1/1(410/410) genotype and allele frequency tended to be higher in mild melasma, although it was statistically insignificant.

References

  1. Irikura, V.M., Lagraoui, M., Hirsh, D., 2002. The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor. J. Immunol. 169, 393–398.
  2. Arend, W.P., 1991. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88, 1445.
  3. Palmer, G., Talabot-Ayer, D., Kaya, G., Gabay, C., 2007. Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation. J. Invest. Dermatol. 127, 1938–1946.
  4. Phillips, W.G., Feldmann, M., Breathnach, S.M., Brennan, F.M., 1995. Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist. Clin. Exp. Immunol. 101, 177–182.
  5. Jiang, J., Zhang, X., Sun, D., Jin, Y., Bai, J., Chen, F., Fu, S., 2010. Study on VNTR polymorphism of gene IL-1RA in 19 Chinese populations. Int. J. Immunogenet. 37, 73–77.
  6. Ritter, C.G., Fiss, D.V.C., Borges da Costa, J.A.T., de Carvalho, R.R., Bauermann, G., Cestari, T.F., 2013. Extra-facial melasma: clinical, histopathological, and immunohistochemical case-control study: Extra-facial melasma: clinic and histopathology. J. Eur. Acad. Dermatol. Venereol. 27, 1088–1094.
  7. Sonthalia, S., Sarkar, R., 2015. Etiopathogenesis of melasma. Pigment Int. 2: 21-7.
  8. Ali, R., Aman, S., Nadeem, M., Kazmi, A.H., 2016. Quality of life in patients of melasma. J. Pak. Assoc. Dermatol. 23, 143–148.
  9. Guarneri, F., 2014. Etiopathogenesis of Melasma. Pigment. Disord. S 1, 1-5
  10. Pandya, A.G., Hynan, L.S., Bhore, R., Riley, F.C., Guevara, I.L., Grimes, P., Nordlund, J.J., Rendon, M., Taylor, S., Gottschalk, R.W., Agim, N.G., Ortonne, J.-P., 2011. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J. Am. Acad. Dermatol. 64, 78–83.
  11. Kim, E.H., Kim, Y.C., Lee, E.-S., Kang, H.Y., 2007. The vascular characteristics of melasma. J. Dermatol. Sci. 46, 111–116.
  12. Bid, H.K., Kumar, A., Mishra, P.K., Mittal, R.D., 2004. Study of interleukin-1 receptor antagonist (IL-1Ra) gene polymorphism in healthy individuals from Northern India. Indian J. Clin. Biochem. 19, 119–123.
  13. Sarkar, R., Arora, P., Garg, V.K., Sonthalia, S., Gokhale, N., 2014. Melasma update. Indian Dermatol. Online J. 5, 426–435.
  14. Lee, A.-Y., 2015. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 28, 648–660.
  15. Passeron, T., 2013. Melasma pathogenesis and influencing factors - an overview of the latest research: Melasma pathogenesis and influencing factors. J. Eur. Acad. Dermatol. Venereol. 27, 5–6.
  16. Suryaningsih, B.E., Sadewa, H., Wirohadidjojo, Y.W., Soebono, H., 2019. Association between heterozygote Val92Met MC1R gene polymorphisms with the incidence of melasma: a study of Javanese women population in Yogyakarta. Journal Clinical, Cosmetical and Investigational Dermatology. Vol 12:489-495
  17. Ortonne, J., Arellano, I., Berneburg, M., Cestari, T., Chan, H., Grimes, P., Hexsel, D., Im, S., Lim, J., Lui, H., Pandya, A., Picardo, M., Rendon, M., Taylor, S., Van Der Veen, J., Westerhof, W., 2009. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J. Eur. Acad. Dermatol. Venereol. 23, 1254–1262
  18. Damevska, K., 2014. New Aspects of Melasma/Novi aspekti melazme. Serbian J. Dermatol. Venereol. 6 (1) 1-15
  19. Hajizadeh, Y.S., Emami, E., Nottagh, M., Amini, Z., Maroufi, N.F., Azimian, S.H., Isazadeh, A., 2017. Effects of interleukin-1 receptor antagonist (IL-1Ra) gene 86 bp VNTR polymorphism on recurrent pregnancy loss: a case-control study. Horm. Mol. Biol. Clin. Investig. 30,1-7
  20. Dinarello, C.A., Thompson, R.C., 1991. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12, 404–410.
  21. Granowitz, E.V., Poutsiaka, D.D., Cannon, J.G., Wolff, S.M., Dinarello, C.A., Santos, A.A., Wilmore, D.W., 1991. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. The Lancet, originally published as Volume 2, Issue 8780 338, 1423–1424.

How to Cite

Ekawati Suryanigsih, B., Sadewa, A. H., Wirohadidjojo, Y. W. ., & Soebono, H. . (2022). Correlation between Polymorphisms Interleukin-1 Receptor Antagonist (IL-1RA) And Melasma Severity: A Study of Javanese Female Population in Yogyakarta. Bali Medical Journal, 11(2), 587–590. https://doi.org/10.15562/bmj.v11i2.3481

HTML
0

Total
0

Share

Search Panel

Betty Ekawati Suryanigsih
Google Scholar
Pubmed
BMJ Journal


Ahmad Hamim Sadewa
Google Scholar
Pubmed
BMJ Journal


Yohanes Widodo Wirohadidjojo
Google Scholar
Pubmed
BMJ Journal


Hardyanto Soebono
Google Scholar
Pubmed
BMJ Journal